Hal Siegel, Ph.D. - Senior Advisor
Dr Siegel has over 20 years experience across R&D and regulatory affairs, and supported multiple VC and public fundraising rounds, founding Siegel Consultancy LLC in 2001. For the past 8 years, Siegel served ImmuneRegen (as Senior VP, Product Development and Regulatory Affairs, and then VP and CSO), then Zila, Inc. (as VP, responsible for the company's Phase 3 oncology program and device activities, as FDA liaison and establishing multiple research collaborations).
From 2000-2003, Siegel served in the FDA-regulated information technology space, in Sun Microsystems Life Sciences Group, and BioQ, integrating regulatory and scientific content into a SaaS product (a collaboration with IBM, Accenture and Autonomy).
Siegel spent 1993-1998 at Advanced Bioresearch Associates, a boutique CRO, providing regulatory, clinical and scientific support, including to a botanical drug startup acquired by Wyeth-Ayerst. He joined ABA following positions at Hybritech Inc. (an Eli Lilly company) and Iatric Corporation, where he was responsible for regulatory and compliance activities for biological products and a monoclonal antibody/drug product.
He obtained his B.S. Biology from RPI, his PhD in Biochemical Pharmacology from SUNY Buffalo and performed post-doctoral research at Los Alamos National Laboratory and at the Barrow Neurological Institute. He serves on the Phoenix Leadership group of AZBio, the Arizona life science industry trade group.
Contact Hal to Learn More
If you'd like a free consultation, please start by completing the following form: